A subunit vaccine against pneumonia: targeting Streptococcus pneumoniae and Klebsiella pneumoniae

[1]  Md. Shahedur Rahman,et al.  Immune epitopes identification and designing of a multi-epitope vaccine against bovine leukemia virus: a molecular dynamics and immune simulation approaches , 2022, Cancer Immunology, Immunotherapy.

[2]  Md. Shahedur Rahman,et al.  Design of a multi-epitope vaccine against SARS-CoV-2: immunoinformatic and computational methods , 2022, RSC advances.

[3]  Md. Shahedur Rahman,et al.  Computer-based identification of potential compounds from Salviae miltiorrhizae against Neirisaral adhesion A regulatory protein , 2020, Journal of biomolecular structure & dynamics.

[4]  Md. Anowar Khasru Parvez,et al.  Combination of QSAR, molecular docking, molecular dynamic simulation and MM-PBSA: analogues of lopinavir and favipiravir as potential drug candidates against COVID-19 , 2020, Journal of biomolecular structure & dynamics.

[5]  Md. Shahedur Rahman,et al.  Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach , 2020, Journal of biomolecular structure & dynamics.

[6]  A. Mishra,et al.  Receptor-ligand based molecular interaction to discover adjuvant for immune cell TLRs to develop next-generation vaccine. , 2020, International journal of biological macromolecules.

[7]  F. Ghaffarifar,et al.  Vaccination with a novel multi-epitope ROP8 DNA vaccine against acute Toxoplasma gondii infection induces strong B and T cell responses in mice. , 2020, Comparative immunology, microbiology and infectious diseases.

[8]  Jianyi Yang,et al.  Improved protein structure prediction using predicted interresidue orientations , 2019, Proceedings of the National Academy of Sciences.

[9]  Amjad Ali,et al.  Immunoinformatics-Aided Design and Evaluation of a Potential Multi-Epitope Vaccine against Klebsiella Pneumoniae , 2019, Vaccines.

[10]  E. Starostina,et al.  In silico Designed Ebola Virus T-Cell Multi-Epitope DNA Vaccine Constructions Are Immunogenic in Mice , 2019, Vaccines.

[11]  Mini P. Singh,et al.  Designing a multi-epitope based vaccine to combat Kaposi Sarcoma utilizing immunoinformatics approach , 2019, Scientific Reports.

[12]  Y. Ghasemi,et al.  Vaccinomics approach for developing multi-epitope peptide pneumococcal vaccine , 2019, Journal of biomolecular structure & dynamics.

[13]  M. U. Mirza,et al.  Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis , 2018, Front. Immunol..

[14]  J. Greenbaum,et al.  Improved methods for predicting peptide binding affinity to MHC class II molecules , 2018, Immunology.

[15]  Syed Shujait Ali,et al.  Computational identification, characterization and validation of potential antigenic peptide vaccines from hrHPVs E6 proteins using immunoinformatics and computational systems biology approaches , 2018, PloS one.

[16]  Radka Svobodová Vařeková,et al.  PDBsum: Structural summaries of PDB entries , 2017, Protein science : a publication of the Protein Society.

[17]  Alexandria K. D’Souza,et al.  Characterization of Inner and Outer Membrane Proteins from Francisella tularensis Strains LVS and Schu S4 and Identification of Potential Subunit Vaccine Candidates , 2017, mBio.

[18]  S. Uppalapati,et al.  Evaluation of Recombinant Multi-Epitope Outer Membrane Protein-Based Klebsiella pneumoniae Subunit Vaccine in Mouse Model , 2017, Front. Microbiol..

[19]  A. Mishra,et al.  Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection , 2017, Scientific Reports.

[20]  S. Madhi,et al.  Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South Africa , 2017, PloS one.

[21]  Carlos Angulo,et al.  A novel design of a multi-antigenic, multistage and multi-epitope vaccine against Helicobacter pylori: An in silico approach. , 2017, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[22]  Daniel Pinho,et al.  Utilization of cholera toxin B as a mucosal adjuvant elicits antibody-mediated protection against S. pneumoniae infection in mice , 2017, Therapeutic advances in vaccines.

[23]  G. Pazour,et al.  Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness , 2017, Scientific Reports.

[24]  M. Netea,et al.  Antigen-Independent Restriction of Pneumococcal Density by Mucosal Adjuvant Cholera Toxin Subunit B. , 2016, The Journal of infectious diseases.

[25]  Li Li,et al.  A novel multi-epitope recombined protein for diagnosis of human brucellosis , 2016, BMC Infectious Diseases.

[26]  M. Dobrovolskaia,et al.  Understanding the immunogenicity and antigenicity of nanomaterials: Past, present and future. , 2016, Toxicology and applied pharmacology.

[27]  Pierre Tufféry,et al.  PEP-FOLD3: faster de novo structure prediction for linear peptides in solution and in complex , 2016, Nucleic Acids Res..

[28]  D. Gu,et al.  Rapid Detection of K1 Hypervirulent Klebsiella pneumoniae by MALDI-TOF MS , 2015, Front. Microbiol..

[29]  R. Heath,et al.  Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection , 2015, Clinical and Vaccine Immunology.

[30]  H. Yoshida,et al.  Evidence for TLR4 and FcRγ-CARD9 activation by cholera toxin B subunit and its direct bindings to TREM2 and LMIR5 receptors. , 2015, Molecular immunology.

[31]  T. Stratmann,et al.  Cholera Toxin Subunit B as Adjuvant––An Accelerator in Protective Immunity and a Break in Autoimmunity , 2015, Vaccines.

[32]  M. Bassetti,et al.  Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. , 2015, The Journal of antimicrobial chemotherapy.

[33]  D. Briles,et al.  Current status and perspectives on protein-based pneumococcal vaccines , 2015, Critical reviews in microbiology.

[34]  Gert Vriend,et al.  New ways to boost molecular dynamics simulations , 2015, J. Comput. Chem..

[35]  Yuanqing Liu,et al.  A Comparative Review of Toll-Like Receptor 4 Expression and Functionality in Different Animal Species , 2014, Front. Immunol..

[36]  M. Pichichero,et al.  Vaccination with a Streptococcus pneumoniae trivalent recombinant PcpA, PhtD and PlyD1 protein vaccine candidate protects against lethal pneumonia in an infant murine model. , 2014, Vaccine.

[37]  Irini A. Doytchinova,et al.  AllergenFP: allergenicity prediction by descriptor fingerprints , 2014, Bioinform..

[38]  Todd M. Gierahn,et al.  Toll-Like Receptor 2-Dependent Protection against Pneumococcal Carriage by Immunization with Lipidated Pneumococcal Proteins , 2014, Infection and Immunity.

[39]  S. Tsai,et al.  SitA contributes to the virulence of Klebsiella pneumoniae in a mouse infection model. , 2014, Microbes and infection.

[40]  Sandeep Kumar Dhanda,et al.  Designing of interferon-gamma inducing MHC class-II binders , 2013, Biology Direct.

[41]  Alan A. Dombkowski,et al.  Disulfide by Design 2.0: a web-based tool for disulfide engineering in proteins , 2013, BMC Bioinformatics.

[42]  Alessandro Sette,et al.  Properties of MHC Class I Presented Peptides That Enhance Immunogenicity , 2013, PLoS Comput. Biol..

[43]  Chaok Seok,et al.  GalaxyRefine: protein structure refinement driven by side-chain repacking , 2013, Nucleic Acids Res..

[44]  Irini A. Doytchinova,et al.  AllerTOP - a server for in silico prediction of allergens , 2013, BMC Bioinformatics.

[45]  Abdelmonaem Messaoudi,et al.  Homology modeling and virtual screening approaches to identify potent inhibitors of VEB-1 β-lactamase , 2013, Theoretical Biology and Medical Modelling.

[46]  Philip E. Bourne,et al.  Immune epitope database analysis resource , 2012, Nucleic Acids Res..

[47]  M. Pichichero,et al.  Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans. , 2012, Vaccine.

[48]  J. Alcorn,et al.  Th17 cells mediate clade-specific, serotype-independent mucosal immunity. , 2011, Immunity.

[49]  M. Lipsitch,et al.  Serotype replacement in disease after pneumococcal vaccination , 2011, The Lancet.

[50]  S. Brunak,et al.  SignalP 4.0: discriminating signal peptides from transmembrane regions , 2011, Nature Methods.

[51]  Ole Lund,et al.  Immune system simulation online , 2011, Bioinform..

[52]  Morten Nielsen,et al.  Peptide binding predictions for HLA DR, DP and DQ molecules , 2010, BMC Bioinformatics.

[53]  J. Bates,et al.  Flagellin as an Adjuvant: Cellular Mechanisms and Potential , 2010, The Journal of Immunology.

[54]  Julie A McMurry,et al.  In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopes. , 2009, Vaccine.

[55]  Chun Meng,et al.  Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease. , 2009, Microbial pathogenesis.

[56]  Wei Li,et al.  ElliPro: a new structure-based tool for the prediction of antibody epitopes , 2008, BMC Bioinformatics.

[57]  D. Moranta,et al.  Klebsiella pneumoniae Increases the Levels of Toll-Like Receptors 2 and 4 in Human Airway Epithelial Cells , 2008, Infection and Immunity.

[58]  Morten Nielsen,et al.  Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction , 2007, BMC Bioinformatics.

[59]  Ruth Nussinov,et al.  FireDock: Fast interaction refinement in molecular docking , 2007, Proteins.

[60]  Wei Li,et al.  Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines , 2007, BMC Bioinformatics.

[61]  Manfred J. Sippl,et al.  Thirty years of environmental health research--and growing. , 1996, Nucleic Acids Res..

[62]  Irini A. Doytchinova,et al.  BMC Bioinformatics BioMed Central Methodology article VaxiJen: a server for prediction of protective antigens, tumour , 2007 .

[63]  G. Vriend,et al.  Fast empirical pKa prediction by Ewald summation. , 2006, Journal of molecular graphics & modelling.

[64]  T. Mitchell,et al.  The Contribution of PspC to Pneumococcal Virulence Varies between Strains and Is Accomplished by Both Complement Evasion and Complement-Independent Mechanisms , 2006, Infection and Immunity.

[65]  John Sidney,et al.  Predicting population coverage of T-cell epitope-based diagnostics and vaccines , 2006, BMC Bioinformatics.

[66]  C. Poh,et al.  Identification of vaccine candidate antigens of an ESBL producing Klebsiella pneumoniae clinical strain by immunoproteome analysis , 2006, Proteomics.

[67]  Torsten Schwede,et al.  BIOINFORMATICS Bioinformatics Advance Access published November 12, 2005 The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling , 2022 .

[68]  Gerrit Groenhof,et al.  GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..

[69]  Jeremy S. Brown,et al.  Additive Inhibition of Complement Deposition by Pneumolysin and PspA Facilitates Streptococcus pneumoniae Septicemia 1 , 2005, The Journal of Immunology.

[70]  O. Lund,et al.  An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions , 2005, European journal of immunology.

[71]  Dieter Jahn,et al.  JCat: a novel tool to adapt codon usage of a target gene to its potential expression host , 2005, Nucleic Acids Res..

[72]  Ruth Nussinov,et al.  PatchDock and SymmDock: servers for rigid and symmetric docking , 2005, Nucleic Acids Res..

[73]  Kathryn Brillinger,et al.  Felis catus System : Terrestrial Kingdom Phylum Class Order Family Animalia Chordata Mammalia Carnivora Felidae , 2022 .

[74]  Sandor Vajda,et al.  ClusPro: a fully automated algorithm for protein-protein docking , 2004, Nucleic Acids Res..

[75]  A. Sette,et al.  Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. , 2003, Current opinion in immunology.

[76]  S. Godefroy,et al.  Outer membrane protein A renders dendritic cells and macrophages responsive to CCL21 and triggers dendritic cell migration to secondary lymphoid organs , 2003, European journal of immunology.

[77]  J. Bonnefoy,et al.  Outer membrane protein A (OmpA): a new pathogen-associated molecular pattern that interacts with antigen presenting cells-impact on vaccine strategies. , 2002, Vaccine.

[78]  Shouxiong Huang,et al.  Outer membrane proteins: key players for bacterial adaptation in host niches. , 2002, Microbes and infection.

[79]  Teruyuki Nagamune,et al.  Design of the linkers which effectively separate domains of a bifunctional fusion protein. , 2001, Protein engineering.

[80]  A. Krogh,et al.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. , 2001, Journal of molecular biology.

[81]  P. Romero,et al.  OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway , 2000, Nature Immunology.

[82]  Liam J. McGuffin,et al.  The PSIPRED protein structure prediction server , 2000, Bioinform..

[83]  J. Paton,et al.  Additive Attenuation of Virulence ofStreptococcus pneumoniae by Mutation of the Genes Encoding Pneumolysin and Other Putative Pneumococcal Virulence Proteins , 2000, Infection and Immunity.

[84]  D. Briles,et al.  The pspC Gene of Streptococcus pneumoniae Encodes a Polymorphic Protein, PspC, Which Elicits Cross-Reactive Antibodies to PspA and Provides Immunity to Pneumococcal Bacteremia , 1999, Infection and Immunity.

[85]  C. Svanborg,et al.  Effects of Active Immunization with a Pneumococcal Surface Protein (PspA) and of Locally Applied Antibodies in Experimental Otitis media , 1999, ORL.

[86]  Y. Guo,et al.  Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. , 1997, The Journal of infectious diseases.

[87]  Christophe Geourjon,et al.  SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments , 1995, Comput. Appl. Biosci..

[88]  A. Cross,et al.  Safety and immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans. , 1986, Vaccine.

[89]  S. Chhibber,et al.  Lipopolysaccharide-mediated protection againstKlebsiella pneumoniae-induced lobar pneumonia: Intranasalvs. intramuscular route of immunization , 2008, Folia Microbiologica.

[90]  J. Paton.  New Pneumococcal Vaccines: Basic Science Developments , 2004 .

[91]  R D Appel,et al.  Protein identification and analysis tools in the ExPASy server. , 1999, Methods in molecular biology.

[92]  in in Humans. , 2021 .